for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BioTelemetry Inc

BEAT.OQ

Latest Trade

38.94USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

37.10

 - 

80.80

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
38.94
Open
--
Volume
--
3M AVG Volume
6.65
Today's High
--
Today's Low
--
52 Week High
80.80
52 Week Low
37.10
Shares Out (MIL)
33.89
Market Cap (MIL)
1,319.65
Forward P/E
30.28
Dividend (Yield %)
--

Next Event

Q3 2019 BioTelemetry Inc Earnings Release

Latest Developments

More

Biotelemetry Q2 GAAP Earnings Per Share $0.23

Itamar Medical And Biotel Heart, A Division Of Biotelemetry Agree To Collaborate

Biotelemetry, Inc. Q1 Adjusted Earnings Per Share $0.42

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About BioTelemetry Inc

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The Company operates in three segments: Healthcare, Technology and Research. The Healthcare segment, operating as CardioNet, LLC and Heartcare Corporation of America, Inc., is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. The Research segment, operating as Cardiocore, LLC and VirtualScopics, Inc., is engaged in laboratory services that provide cardiac monitoring, imaging services, scientific consulting and data management services for drug, medical treatment and device trials. The Technology segment, operating as Braemar Manufacturing, LLC, Universal Medical, Inc. and BioTelemetry Belgium BVBA. and BioTelemetry Technology ApS, focuses on the manufacturing, engineering and development of noninvasive cardiac monitors for healthcare companies.

Industry

Healthcare Facilities

Contact Info

1000 Cedar Hollow Rd

+1.610.7297000

https://www.gobio.com/

Executive Leadership

Kirk E. Gorman

Independent Chairman of the Board

Joseph H. Capper

President, Chief Executive Officer, Director

Heather C. Getz

Chief Financial Officer, Executive Vice President

Fred Anthony Broadway

President, BioTel Heart

Peter F. Ferola

Senior Vice President, General Counsel and Corporate Secretary

Key Stats

1.80 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.2K

2017

0.3K

2018

0.4K

2019(E)

0.4K
EPS (USD)

2016

0.850

2017

0.970

2018

1.940

2019(E)

1.976
Price To Earnings (TTM)
30.42
Price To Sales (TTM)
3.15
Price To Book (MRQ)
3.80
Price To Cash Flow (TTM)
15.19
Total Debt To Equity (MRQ)
56.98
LT Debt To Equity (MRQ)
53.85
Return on Investment (TTM)
8.38
Return on Equity (TTM)
7.65

Latest News

Latest News

BRIEF-Biotelemetry Inc Q1 GAAP Earnings Per Share $0.17

* BIOTELEMETRY, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-BioTelemetry Reports Q4 Adjusted Earnings Per Share $0.32

* BIOTELEMETRY, INC. REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS

BRIEF-BioTelemetry Inc Partners With Apple To Provide Cardiac Monitoring Services

* BIOTELEMETRY INC - ANNOUNCED PARTNERSHIP WITH APPLE TO PROVIDE CARDIAC MONITORING SERVICES IN CONJUNCTION WITH APPLE HEART STUDY Source text for Eikon: Further company coverage:

BRIEF-Biotelemetry posts Q3 adjusted earnings per share $0.16

* Biotelemetry Inc reports third quarter 2017 financial results

BRIEF-Biotelemetry Q2 adjusted earnings per share $0.23

* Biotelemetry, inc. Reports second quarter 2017 financial results

BRIEF-Biotelemetry enters credit agreement related to Lifewatch acquisition

* Biotelemetry Inc - on July 12 in connection with closing of acquisition of Lifewatch AG entered into a credit agreement - SEC filing

BRIEF-Lifewatch: BioTelemetry confirms success rate of 96.67 pct​

* WITH DEFINITIVE END RESULT NOW AVAILABLE, BIOTELEMETRY (NASDAQ: BEAT) ( OFFEROR) CONFIRMED TODAY SUCCESS RATE OF 96.67 PERCENT Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Lifewatch: BioTelemetry holds 96.5% of share capital of Lifewatch

* BIOTELEMETRY HOLDS 17,831,214 LIFEWATCH SHARES, CORRESPONDING TO 96.50% OF VOTING RIGHTS AND SHARE CAPITAL OF LIFEWATCH Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Lifewatch: 82 pct of shares of Lifewatch​ tendered

* EQS-ADHOC: LIFEWATCH AG: BIOTELEMETRY, INC. RELEASES PROVISIONAL INTERIM RESULT OF PUBLIC OFFER FOR LIFEWATCH AG

BRIEF-Lifewatch: Biotelemetry announces extension of main offer period for public offer

* LIFEWATCH AG: BIOTELEMETRY, INC. ANNOUNCES EXTENSION OF THE MAIN OFFER PERIOD FOR PUBLIC OFFER FOR LIFEWATCH AG

BRIEF-LifeWatch and BioTelemetry announce receipt of antitrust clearance

* LIFEWATCH AG AND BIOTELEMETRY, INC. ANNOUNCE RECEIPT OF ANTITRUST CLEARANCE

BRIEF-BioTelemetry announces receipt of antitrust clearance for its acquisition of LifeWatch AG

* Biotelemetry, inc. Announces receipt of antitrust clearance for its acquisition of lifewatch ag

BRIEF-Biotelemetry Q1 adjusted earnings per share $0.16

* Biotelemetry Inc reports first quarter 2017 financial results

BRIEF-Biotelemetry issues prospectus for public tender offer

* Biotelemetry, Inc. issues prospectus for public tender offer to acquire lifewatch ag

BRIEF-Lifewatch: BioTelemetry launches tender offer

* Said on Sunday BioTelemetry, Inc. launches a tender offer to acquire Lifewatch AG

BRIEF-BioTelemetry launches tender offer to acquire Lifewatch AG

* BioTelemetry, Inc launches a tender offer to acquire Lifewatch AG

BRIEF-BioTelemetry files for mixed shelf of up to $200 mln

* Files for mixed shelf of up to $200.0 million - SEC filing Source text: (http://bit.ly/2l3AnwT) Further company coverage:

BRIEF-Biotelemetry reports Q4 GAAP EPS $1.30

* Biotelemetry, inc. Reports fourth quarter and full year 2016 financial results

BRIEF-Biotelemetry Inc Q3 adj EPS $0.21 vs I/B/E/S view $0.18

* BioTelemetry Inc - expect to achieve higher end of 2016 adjusted EBITDA guidance of $44 to $46 million

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up